Arcadia Biosciences
RKDA
14 hedge funds and large institutions have $222K invested in Arcadia Biosciences in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
8% more funds holding
Funds holding: 13 → 14 (+1)
0.15% less ownership
Funds ownership: 5.73% → 5.58% (-0.15%)
52% less capital invested
Capital invested by funds: $465K → $222K (-$243K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mariner
Overland Park,
Kansas
|
+$10.7K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.16K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.89K |
| 4 |
LFG
Larson Financial Group
St Louis,
Missouri
|
+$4 |
| 5 |
Morgan Stanley
New York
|
+$4 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$23.3K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$444 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Mariner
Overland Park,
Kansas
| $81.6K | +$10.7K | +2,481 | +10% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $39.9K | – | – | – |
|
|
3
Geode Capital Management
Boston,
Massachusetts
| $36.3K | +$2.16K | +498 | +4% |
|
4
State Street
Boston,
Massachusetts
| $34.5K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $25.4K | -$23.3K | -5,385 | -39% |
|
|
6
Morgan Stanley
New York
| $1.81K | +$4 | +1 | +0.2% |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $1.3K | +$1.89K | +437 | New |
|
|
AWM
8
Atticus Wealth Management
Palm Beach Gardens,
Florida
| $808 | – | – | – |
|
|
SS
9
SBI Securities
Tokyo,
Japan
| $356 | – | – | – |
|
10
Group One Trading
Chicago,
Illinois
| $51 | – | – | – |
|
11
Bank of America
Charlotte,
North Carolina
| $33 | – | – | – |
|
12
AssetMark Inc
Concord,
California
| $15 | – | – | – |
|
|
HI
13
Harbour Investments
Madison,
Wisconsin
| $3 | – | – | – |
|
|
LFG
14
Larson Financial Group
St Louis,
Missouri
| $3 | +$4 | +1 | New |
|
|
15
Osaic Holdings
Scottsdale,
Arizona
| – | -$444 | -75 | Closed |
|
RKDA Hedge Fund Activity: Q1 2025 in Review
14 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q1 2025, worth a combined $222K — down 52% from $465K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new RKDA positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Mariner, adding an estimated $10.7K. The largest seller was UBS Group, cutting an estimated $23.3K.
- 14 institutional investors held Arcadia Biosciences (RKDA) as of Q1 2025, up from 13 in Q4 2024.
- Funds reported $222K of Arcadia Biosciences stock for Q1 2025, down 52% quarter-over-quarter.
- 2 funds opened new Arcadia Biosciences positions in Q1 2025 and 1 closed out, a net change of +1 holder.
- The largest Arcadia Biosciences buyer in Q1 2025 was Mariner, an estimated $10.7K added.
- The largest Arcadia Biosciences seller in Q1 2025 was UBS Group, an estimated $23.3K sold.
Based on aggregated 13F filings for Q1 2025.